Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial Meeting Abstract
| Authors: | Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; Hettich, G.; Jihad, M.; Folefac, E.; Huang, W. C.; Bajorin, D. F.; Iyer, G.; Bochner, B. H.; Balar, A. V.; Mortazavi, A.; Rosenberg, J. E. |
| Abstract Title: | Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602265 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4517 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4517 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
